Articles From: Karyopharm Presents Positive Clinical Data for Selinexor (KPT-330) in NHL Patients at ASH 2014 Annual Meeting to Daniel Norselli Named President and Publisher of the Springfield News-Leader and The Baxter Bulletin


Levi & Korsinsky is investigating the Board of Directors of Spansion, Inc. (“Spansion” or “the Company”) (NYSE: CODE) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Cypress Semiconductor Corporation (“Cypress”) (NasdaqGS: CY). Click here to learn more about the investigation: http://zlk.9nl.com/spansion-code .
Sign-up for INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Spansion, Inc. Regarding the Fairness of the Sale of the Company to Cypress Semiconductor Corp. -- CODE investment picks
Boutique hotel brand celebrates U.S. debut in historic Cotton Exchange building in New Orleans NEW ORLEANS , Dec.
Sign-up for AC Hotels by Marriott Imports European Sophistication To North America investment picks
Former United States Securities and Exchange Commission attorney Willie Briscoe , founder of The Briscoe Law Firm, PLLC , and the securities litigation firm of Powers Taylor LLP announce that a class action lawsuit has been filed against Rayonier, Inc. (“Rayonier” or “Company”) (NYSE: RYN) and several officers and directors for acts taken during the period of April 29, 2014 to November 10, 2014 (the “Class Period”). Based upon the allegations in the class action, the firms are investigating additional legal claims against the officers and Board of Directors of Rayonier.
Sign-up for Rayonier, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors investment picks
Keysight Technologies, Inc. (NYSE:KEYS) today announced that Frost & Sullivan has recognized Keysight with the 2014 Global Frost & Sullivan Award for Market Leadership in Instrumentation Software for excellence in capturing the highest market revenue within its industry.
Sign-up for TRADE NEWS: Keysight Technologies Receives 2014 Global Frost & Sullivan Award for Market Leadership in Instrumentation Software investment picks
- Selinexor Demonstrates Synergy in Combination with Approved Therapies for Multiple Myeloma - NEWTON, Mass., Dec.
Sign-up for Karyopharm Presents Positive Combination Data for Selinexor (KPT-330) in Multiple Myeloma Patients at ASH 2014 Annual Meeting investment picks
ICF International (NASDAQ:ICFI), a leading provider of consulting services and technology solutions to government and commercial clients, has named Jim Lawler senior vice president for human resources (HR). Mr.
Sign-up for ICF International Names Jim Lawler Senior Vice President for Human Resources investment picks
Adobe (Nasdaq:ADBE) today announced it will webcast its fourth quarter and fiscal year 2014 earnings conference call to be held later this week.
Sign-up for Adobe to Webcast Q4 and FY14 Earnings Conference Call investment picks
Westwood Holdings Group (NYSE: WHG), a Dallas-based investment management firm, tops the list for the 2014 Best Places to Work in Money Management by Pensions & Investments magazine today.
Sign-up for Westwood Holdings Group Named First in Pensions & Investments’ 2014 “Best Places to Work in Money Management” investment picks
December 8, 2014 -- Comtech Telecommunications Corp.
Sign-up for Comtech Telecommunications Corp. Received $3.5 Million Order for SATCOM Infrastructure Equipment for Deployment in Government Network investment picks
Foundation Medicine, Inc. (NASDAQ:FMI) today announced new data demonstrating that its comprehensive genomic profile, FoundationOne® Heme , identified genomic alterations in patients with heavily pre-treated multiple myeloma that informed treatment with trametinib, an FDA-approved targeted therapeutic agent 1 .
Sign-up for Treatment for Relapsed Multiple Myeloma Patients Guided by FoundationOne® Heme Results in Promising Clinical Activity investment picks
AG-348 Achieved Proof-of-Mechanism Through Substantial Effects on Two Key Biomarkers of Pyruvate Kinase Activity and Pathway Activation SAN FRANCISCO, Dec.
Sign-up for Agios Reports Positive Phase 1 Data in Healthy Volunteers for AG-348, a First-in-Class Investigational Medicine That Targets the Underlying Cause of Pyruvate Kinase (PK) Deficiency investment picks
Dr Pepper Snapple Group (NYSE:DPS) has again been named a member of The Civic 50 , an annual initiative that identifies and recognizes companies for their commitment to improving the quality of life in the communities where they operate.
Sign-up for Dr Pepper Snapple Group Recognized as a Top Community-Minded Company for Third Consecutive Year investment picks
NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N.
Sign-up for NeuroMetrix to Participate in the Benchmark Micro Cap Discovery Conference investment picks
http://media.marketwire.com/attachments/201210/93714_sgbklogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1163636&ProfileId=051205&sourceType=1 POMPANO BEACH, FL --
Sign-up for Stonegate Bank Declares Quarterly Cash Dividend investment picks
Sayles Werbner's verdict for Commil USA now focus of important high court case DALLAS , Dec.
Sign-up for US Supreme Court to Hear Appeal in Patent Fight with Cisco investment picks
CHARLOTTE, N.C. , Dec.
Sign-up for N.C. regulators approve Duke Energy's request to build 3 solar facilities investment picks
JNS Holdings Corporation (OTC: JNSH), an owner/operator & installer of electric vehicle (EV) charging stations and commercial licensed electrical contractor specializing in all types of controls and services throughout the Chicagoland area, today announced that JNS has received contracts to provide fire alarm detection installations at the Ontario, Sears, Dearborn & Plymouth substations to upgrade the existing fire alarm systems.
Sign-up for JNS Holdings Subsidiary Awarded Contracts for Four Detection Installations investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Karyopharm Presents Positive Clinical Data for Selinexor (KPT-330) in NHL Patients at ASH 2014 Annual Meeting to Daniel Norselli Named President and Publisher of the Springfield News-Leader and The Baxter Bulletin
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent